Post by Logan on Jun 8, 2016 3:40:45 GMT -6
Drugmakers pay $67 million to settle claims they exaggerated cancer drug's effectiveness
Genentech and another drugmaker will pay $67 million to settle claims that they misled doctors into prescribing a treatment to lung cancer patients for whom the companies knew it would not work.
As a result, some patients may have died earlier than they would have if they had taken more effective drugs, a lawsuit brought by a former Genentech employee and joined by federal prosecutors alleges.
“Cancer patients only get one shot at first-line treatments,” the lawsuit said, “and defendants took that opportunity away.”
Genentech of South San Francisco said it settled the claims to avoid more costly litigation over marketing of the drug, Tarceva.
Read more: www.latimes.com/business/la-fi-genentech-tarceva-settlement-20160607-snap-story.html
Genentech and another drugmaker will pay $67 million to settle claims that they misled doctors into prescribing a treatment to lung cancer patients for whom the companies knew it would not work.
As a result, some patients may have died earlier than they would have if they had taken more effective drugs, a lawsuit brought by a former Genentech employee and joined by federal prosecutors alleges.
“Cancer patients only get one shot at first-line treatments,” the lawsuit said, “and defendants took that opportunity away.”
Genentech of South San Francisco said it settled the claims to avoid more costly litigation over marketing of the drug, Tarceva.
Read more: www.latimes.com/business/la-fi-genentech-tarceva-settlement-20160607-snap-story.html